Asthma Assessment (NQF 0001)

eMeasure Name Asthma Assessment eMeasure Id 59B24505-B9D1-48B8-BEB2-AF35219AA689
Version number 1 eMeasure Set Id 876C00EF-5669-424D-8998-391DF9C41C59
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward American Medical Association - Physician Consortium for Performance Improvement
Endorsed by National Quality Forum
Description Percentage of patients aged 5 through 40 years with a diagnosis of asthma who were evaluated during at least one office visit within 12 months for the frequency (numeric) of daytime and nocturnal asthma symptoms.
Copyright 
© 2010 American Medical Association.  All Rights Reserved
Measure scoring Proportion
Measure type Process
Stratification 
None
Risk Adjustment 
None
Data Aggregation 

            

            

               Rationale
               
Appropriate treatment of asthma patients requires accurate classification of asthma severity. Physician assessment of the frequency of asthma symptoms is the first step in classifying asthma severity.

            

            

               Clinical Recommendation Statement
               
To determine whether the goals of therapy are being met, monitoring is recommended in the 6 areas listed below: 
• Signs and symptoms (daytime; nocturnal awakening) of asthma
• Pulmonary function (spirometry; peak flow monitoring)
• Quality of life/functional status
• History of asthma exacerbations
• Pharmacotherapy (as-needed use of inhaled short-acting beta2-agonist, adherence to regimen of long-term-control medications)
• Patient-provider communication and patient satisfaction (NAEPP/NHLBI)

            

            

               Improvement notation
               
Higher score indicates better quality

            

            

               Measurement duration
               
12 month(s)

            

            

               Reference
               
National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health; July 1997. NIH Publication No. 97-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm. Accessed August 2002.

            

            

               Reference
               
National Asthma Education and Prevention Program Expert Panel Report 2 Update: Guidelines for the diagnosis and management of asthma – update on selected topics 2002. National Heart, Lung, and Blood Institute, National Institutes of Health; August 2002. NIH Publication No. 97-4051. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthsumm.htm. Accessed September 2002.

            

            

               Definition
               
Initial Patient Population(s): Patient Age:  Patients aged 5 through 40 years at the beginning of the measurement period.
	
Diagnosis Active:  Patient has a documented diagnosis of asthma.

Encounter:  At least 2 visits with the physician, physician's assistant, or nurse practitioner during the measurement period.

            

            

               Definition
               
Denominator(s): All patients aged 5 through 40 years with a diagnosis of asthma.

            

            

               Definition
               
Denominator Exclusion(s): N/A

            

            

               Definition
               
Numerator(s): Patients who were evaluated during at least one office visit within 12 months for the frequency (numeric) of daytime and nocturnal asthma symptoms.

            

            

               Definition
               
Denominator Exception(s): N/A

            

            

               Guidance
               
The numerator specifies that daytime and nighttime symptoms are assessed. However, the intent of the measure is that both daytime and nighttime symptoms are quantified. The terminology allowed differentiation between daytime and nighttime symptoms, but it did not allow sufficient ability to quantify such symptoms. It is expected that symptoms will be quantified in the patient's record

            

            

               Supplemental Data Elements
               
Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".

            

         
      

      
Table of Contents

      
      

      
Population criteria

      

         
         
         
      

      
Data criteria (QDM Data Elements)

      

         
         
         
      

      
Supplemental Data Elements

      

         
         
         
      



         
            

               Measure set
               CLINICAL QUALITY MEASURE SET 2011-2012